We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Arkema (ARKAY) Unveils New Pebax Elastomer Unit in France
Read MoreHide Full Article
Arkema S.A. (ARKAY - Free Report) recently started its new Pebax elastomer unit at the Serquigny facility in France. This new unit, constructed with cutting-edge industrial processes, can make both bio-circular Pebax Rnew and traditional Pebax elastomers.
These innovative materials are widely utilized in sports equipment such as running shoes, soccer shoes and ski boots, as well as in electrical gadgets and other niche industries such as antistatic additives and medical devices.
Arkema has beefed up its global manufacturing capacity for Pebax elastomers by 40% at the Serquigny plant to support its customers’ growth, especially in the sports and consumer goods markets.
This presents a significant opportunity for Arkema to meet growing demand in existing and new applications while also enhancing its operations, as water usage at the facility will be decreased by around 25%.
Arkema's portfolio of first-class solutions addresses the ever-increasing demand for innovative and sustainable materials, building on its unique combination of materials science knowledge. Arkema provides cutting-edge technology solutions to address difficulties such as new energies, water access, recycling, urbanization and mobility, and maintains open lines of communication with all of its stakeholders.
Shares of Arkema have gained 7% over the past year against a 22.9% decline of its industry.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Arkema currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks in the basic materials space include Cameco Corporation (CCJ - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Alpha Metallurgical Resources Inc. (AMR - Free Report) .
Cameco, carrying a Zacks Rank #1 (Strong Buy), has a projected earnings growth rate of 188% for the current year. The Zacks Consensus Estimate for CCJ’s current-year earnings has been revised upward by 12.5% in the past 60 days. The stock is up around 71.6% in a year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Carpenter Technology currently carries a Zacks Rank #1. CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 12.2%. The company’s shares have soared 20% in the past year.
The Zacks Consensus Estimate for AMR’s current-year earnings has been revised upward by 69% in the past 60 days. It currently carries a Zacks Rank #1. AMR delivered a trailing four-quarter earnings surprise of roughly 9.6%, on average. AMR shares are up around 125.6% in a year.
See More Zacks Research for These Tickers
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Arkema (ARKAY) Unveils New Pebax Elastomer Unit in France
Arkema S.A. (ARKAY - Free Report) recently started its new Pebax elastomer unit at the Serquigny facility in France. This new unit, constructed with cutting-edge industrial processes, can make both bio-circular Pebax Rnew and traditional Pebax elastomers.
These innovative materials are widely utilized in sports equipment such as running shoes, soccer shoes and ski boots, as well as in electrical gadgets and other niche industries such as antistatic additives and medical devices.
Arkema has beefed up its global manufacturing capacity for Pebax elastomers by 40% at the Serquigny plant to support its customers’ growth, especially in the sports and consumer goods markets.
This presents a significant opportunity for Arkema to meet growing demand in existing and new applications while also enhancing its operations, as water usage at the facility will be decreased by around 25%.
Arkema's portfolio of first-class solutions addresses the ever-increasing demand for innovative and sustainable materials, building on its unique combination of materials science knowledge. Arkema provides cutting-edge technology solutions to address difficulties such as new energies, water access, recycling, urbanization and mobility, and maintains open lines of communication with all of its stakeholders.
Shares of Arkema have gained 7% over the past year against a 22.9% decline of its industry.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Arkema currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks in the basic materials space include Cameco Corporation (CCJ - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Alpha Metallurgical Resources Inc. (AMR - Free Report) .
Cameco, carrying a Zacks Rank #1 (Strong Buy), has a projected earnings growth rate of 188% for the current year. The Zacks Consensus Estimate for CCJ’s current-year earnings has been revised upward by 12.5% in the past 60 days. The stock is up around 71.6% in a year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Carpenter Technology currently carries a Zacks Rank #1. CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 12.2%. The company’s shares have soared 20% in the past year.
The Zacks Consensus Estimate for AMR’s current-year earnings has been revised upward by 69% in the past 60 days. It currently carries a Zacks Rank #1. AMR delivered a trailing four-quarter earnings surprise of roughly 9.6%, on average. AMR shares are up around 125.6% in a year.